 |
| BY READING THIS EMAIL YOU CERTIFY YOU HAVE READ THE DISCLAIMER BELOW AND THE FULL DISCLAIMER PROVIDED THROUGH A LINK AT THE END OF THIS EMAIL. This is a paid advertisement. SmallCapVoice.com, Inc. is not responsible or held liable for the information in the press releases issued by the companies in these emails. Please always do your own due diligence. |
|---|
|
   |
| PSID's Initial Steps for Firefly Dx to Enter Yet Another Lucrative Market Segment |
|
 Hot Stock to Watch |
Company: PositiveID Corporation (OTCQB: PSID)
|
Last:
Price: 0.033
Change (%): - 0.0005 (1.49)
Volume: 795,387 |
 |
PositiveID and seqID Conduct Pilot Study Using Firefly Dx Prototype for GMO Detection for Agricultural Market
The global market for food-safety testing is projected to reach 19.7 billion dollars by 2018, with GMO testing experiencing the fastest-growth
DELRAY BEACH, Fla. and TORONTO, Sept. 20, 2016 (GLOBE NEWSWIRE) - PositiveID Corporation (“PositiveID” or “Company”) (OTCQB:PSID), a life sciences company focused on detection and diagnostics, announced today that it is conducting a pilot study with seqID inc using PositiveID’s Firefly Dx polymerase chain reaction (“PCR”) breadboard prototype pathogen detection system (“prototype system”) to detect genetically modified organisms (“GMOs”) for the agricultural market.
The goal of the pilot study with seqID is to demonstrate that Firefly Dx can successfully detect the 35S promoter gene in samples of GMO corn and soy beans. It is estimated that 80 percent of all GMO plants contain this gene and it is considered a hallmark of GMOs.
The application of using Firefly Dx to detect genetically modified corn and soybeans in a semi-quantitative analysis has significant potential value at seaports where corn and soybeans are being shipped to countries that limit the percentage of GMOs in the shipment that may be imported. Currently, all such sampling and testing is conducted in a centralized laboratory and may take as long as two weeks, potentially delaying shipment. Firefly Dx would allow a laboratory grade result within 30 minutes at “dock side,” thereby greatly speeding up the shipment time.
PositiveID is developing the Firefly Dx prototype system to be a handheld, fully automated, lab quality, real-time device able to detect pathogens at the point of need. A design advantage of Firefly Dx is that it does not require additional equipment or separate steps for sample preparation and purification, unlike current lab-based equipment, thus reducing time to results as well as cost per test. Firefly’s applications include point-of-need, lab-quality, detection of pathogenic organisms; agricultural and food screening in both domestic sectors and developing countries; and detection of biological agents associated with weapons of mass destruction.
Continue Reading
|
  |
IMPORTANT DISCLAIMER - PLEASE READ THOROUGHLY
SmallCapVoice (SCV) is an electronic publication. Information sources for our profiles include, but are not limited to, online research, member suggestions, magazines, newspapers, analyst suggestions, publicly available material information provided by the profiled company, press releases and similar sources. This communication is not an offer to sell or a recommendation that you buy or sell any security. SCV holds no securities licenses and is not qualified to provide investment advice. We are compensated for these advertisements by the profiled companies. You should not use this newsletter as the sole basis for any investment decision. While all investments involve risk, microcap stocks are among the most risky. Many microcap companies have no proven track record. You should only invest in microcap companies if you can afford to lose your entire investment. You should consult a qualified, licensed financial advisor or stock broker before making any decisions to invest in the securities of any company that is described in these profiles. These profiles are paid advertisements. Although we have a reasonable belief that the information in each profile is accurate, we cannot guarantee that this information, which originates from third parties, is accurate. We do not have the resources to confirm the accuracy of all information obtained from third parties. It is important for you to verify all information by your own independent research. You are receiving this message because you have agreed to receive emails from SmallCapVoice.com. You may opt out of our distribution list at any time by clicking on the “unsubscribe” link below. Link to full disclosure about compensation paid to SmallCapVoice.com, Inc. by companies featured on our website or in our e-mail communications. |
About Penny Stocks |
|
|
